↓ Skip to main content

LC-MS in Drug Analysis

Overview of attention for book
Cover of 'LC-MS in Drug Analysis'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 An Introduction to Drug Testing: The Expanding Role of Mass Spectrometry
  3. Altmetric Badge
    Chapter 2 LC-MS vs. GC-MS, Online Extraction Systems, Advantages of Technology for Drug Screening Assays.
  4. Altmetric Badge
    Chapter 3 LC-MS/MS Techniques for High-Volume Screening of Drugs of Abuse and Target Drug Quantitation in Urine/Blood Matrices
  5. Altmetric Badge
    Chapter 4 Benzodiazepines and Metabolites from Biological Fluids by Liquid Chromatography Electrospray Tandem Mass Spectrometry
  6. Altmetric Badge
    Chapter 5 Opiate Screening and Quantitation in Urine/Blood Matrices Using LC-MS/MS Techniques
  7. Altmetric Badge
    Chapter 6 Synthetic Opioid Analysis by LC-MS/MS
  8. Altmetric Badge
    Chapter 7 The Determination of Cannabinoids Using Liquid Chromatography with Mass Spectrometric Detection
  9. Altmetric Badge
    Chapter 8 Cocaine and Metabolites by LC-MS/MS
  10. Altmetric Badge
    Chapter 9 Quantitation of Amphetamine-Type Stimulants by LC-MS/MS
  11. Altmetric Badge
    Chapter 10 Detection of Prohibited Substances by Liquid Chromatography Tandem Mass Spectrometry for Sports Doping Control
  12. Altmetric Badge
    Chapter 11 LC-MS/MS Screen for Xenobiotics and Metabolites
  13. Altmetric Badge
    Chapter 12 Qualitative Identification of Rodenticide Anticoagulants by LC-MS/MS
  14. Altmetric Badge
    Chapter 13 Hypoglycemic Agent Screening by LC-MS/MS
  15. Altmetric Badge
    Chapter 14 LC-MS/MS Method for the Detection of Common Laxatives
  16. Altmetric Badge
    Chapter 15 Simultaneous determination of cyclosporine, sirolimus, and tacrolimus in whole blood using liquid chromatography-tandem mass spectrometry.
  17. Altmetric Badge
    Chapter 16 Quantification of Tricyclic Antidepressants Using UPLC-MS/MS.
  18. Altmetric Badge
    Chapter 17 Quantitation of First- and Second-Generation Antipsychotics by LC-MS/MS
  19. Altmetric Badge
    Chapter 18 Analysis of Selected Anticonvulsants by High Performance Liquid Chromatography-Tandem Mass Spectrometry
  20. Altmetric Badge
    Chapter 19 Therapeutic Drug Monitoring of Tamoxifen Using LC-MS/MS.
Attention for Chapter 19: Therapeutic Drug Monitoring of Tamoxifen Using LC-MS/MS.
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Therapeutic Drug Monitoring of Tamoxifen Using LC-MS/MS.
Chapter number 19
Book title
LC-MS in Drug Analysis
Published in
Methods in molecular biology, July 2012
DOI 10.1007/978-1-61779-934-1_19
Pubmed ID
Book ISBNs
978-1-61779-933-4, 978-1-61779-934-1
Authors

Tchu SM, Lynch KL, Wu AH, Simone M. Tchu, Kara L. Lynch, Alan H. B. Wu, Tchu, Simone M., Lynch, Kara L., Wu, Alan H. B.

Abstract

Tamoxifen is a selective estrogen receptor modulator (SERM) that is used widely in the treatment of estrogen receptor positive breast cancer (ER+). Therapeutic monitoring of tamoxifen, and its metabolites N-desmethyltamoxifen (NDTam) and 4-hydroxy-N-desmethyltamoxifen (endoxifen), may be clinically useful for guiding treatment decisions. Two significant barriers to tamoxifen efficacy are: (1) variability in conversion of tamoxifen into the potent antiestrogenic metabolite, endoxifen, and (2) poor compliance and adherence to tamoxifen therapy. Therapeutic monitoring can be used to address both of these issues. Low levels of endoxifen indicate either poor compliance or poor metabolism of tamoxifen. Low tamoxifen levels would suggest poor compliance while a low ratio of endoxifen to NDTam would be indicative of poor metabolism. Solid phase extraction of patient serum followed by liquid chromatography tandem mass spectrometry (LC-MS/MS) detection enables rapid, accurate, detection of tamoxifen, N-desmethyltamoxifen, and endoxifen.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 4%
United States 1 4%
Brazil 1 4%
Unknown 24 89%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 30%
Researcher 3 11%
Professor > Associate Professor 3 11%
Unspecified 2 7%
Student > Master 2 7%
Other 5 19%
Unknown 4 15%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 15%
Medicine and Dentistry 4 15%
Chemistry 4 15%
Biochemistry, Genetics and Molecular Biology 3 11%
Psychology 3 11%
Other 5 19%
Unknown 4 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 August 2012.
All research outputs
#18,313,878
of 22,675,759 outputs
Outputs from Methods in molecular biology
#7,828
of 13,037 outputs
Outputs of similar age
#126,899
of 164,723 outputs
Outputs of similar age from Methods in molecular biology
#35
of 63 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,037 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,723 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.